• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型黏液纤维肉瘤细胞系SMU-MFS的建立与鉴定

Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS.

作者信息

Nakahashi Naoya, Emori Makoto, Takada Kohichi, Murahashi Yasutaka, Shimizu Junya, Murase Kazuyuki, Tsukahara Tomohide, Sugita Shintaro, Takasawa Akira, Iba Kousuke, Teramoto Atsushi, Osanai Makoto

机构信息

Department of Orthopaedic Surgery, Sapporo Medical University School of Medicine, West 16, South 1, Chuo-ku, Sapporo, 060-8543, Japan.

Departments of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

出版信息

Hum Cell. 2024 Dec 3;38(1):25. doi: 10.1007/s13577-024-01157-9.

DOI:10.1007/s13577-024-01157-9
PMID:39625530
Abstract

Myxofibrosarcoma (MFS) is one of the most common soft-tissue sarcomas in elderly patients. Owing to the limited efficacy of chemotherapy and radiotherapy, complete resection is the only available curative treatment. Therefore, developing novel therapies for MFS is important to improve clinical outcomes. Herein, a novel MFS cell line, namely SMU-MFS, was established to better understand the biologic characteristics of MFS and develop new therapies. A tissue sample from the surgically resected tumor tissue of a 56-year-old patient with a tumor was subjected to primary culture. The cell line was established and authenticated by assessing the short tandem repeats of DNA microsatellites. The monolayer cultures of SMU-MFS cells exhibited constant growth, spheroid formation, and invasive capacity. Furthermore, the cells exhibited low chemosensitivity to doxorubicin, eribulin, and pazopanib, which are used to inhibit metastatic progression. In addition, of the four mice inoculated with SMU-MFS cells, tumors developed in two mice after 8 weeks. Altogether, the findings of this study suggest that the SMU-MFS cell line can be a useful tool for investigating MFS development and evaluating novel therapeutic agents.

摘要

黏液纤维肉瘤(MFS)是老年患者中最常见的软组织肉瘤之一。由于化疗和放疗的疗效有限,完整切除是唯一可行的治愈性治疗方法。因此,开发针对MFS的新疗法对于改善临床结果至关重要。在此,建立了一种新的MFS细胞系,即SMU-MFS,以更好地了解MFS的生物学特性并开发新疗法。对一名56岁肿瘤患者手术切除的肿瘤组织样本进行原代培养。通过评估DNA微卫星的短串联重复序列来建立和鉴定该细胞系。SMU-MFS细胞的单层培养表现出持续生长、球体形成和侵袭能力。此外,这些细胞对用于抑制转移进展的阿霉素、艾日布林和帕唑帕尼表现出低化学敏感性。另外,在接种SMU-MFS细胞的四只小鼠中,有两只小鼠在8周后长出了肿瘤。总之,本研究结果表明,SMU-MFS细胞系可成为研究MFS发展和评估新型治疗药物的有用工具。

相似文献

1
Establishment and characterization of the novel myxofibrosarcoma cell line, SMU-MFS.新型黏液纤维肉瘤细胞系SMU-MFS的建立与鉴定
Hum Cell. 2024 Dec 3;38(1):25. doi: 10.1007/s13577-024-01157-9.
2
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS4-C1:一种新型黏液纤维肉瘤的患者来源细胞系。
Hum Cell. 2021 Nov;34(6):1911-1918. doi: 10.1007/s13577-021-00589-x. Epub 2021 Aug 12.
3
Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.一种携带异柠檬酸脱氢酶1(IDH1)突变的新型去分化软骨肉瘤细胞系SMU-DDCS的建立与鉴定
Hum Cell. 2023 Nov;36(6):2195-2203. doi: 10.1007/s13577-023-00944-0. Epub 2023 Jul 15.
4
Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1.建立并鉴定源自黏液纤维肉瘤的两个新型患者源性细胞系:NCC-MFS7-C1 和 NCC-MFS8-C1。
Hum Cell. 2024 Nov;37(6):1742-1750. doi: 10.1007/s13577-024-01124-4. Epub 2024 Aug 31.
5
Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.建立并鉴定 NCC-MFS5-C1:一种新型黏液纤维肉瘤患者来源细胞系。
Cells. 2022 Jan 8;11(2):207. doi: 10.3390/cells11020207.
6
Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS2-C1:一种新型黏液纤维肉瘤的患者来源癌细胞系。
Hum Cell. 2021 Jan;34(1):246-253. doi: 10.1007/s13577-020-00420-z. Epub 2020 Sep 1.
7
Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS6-C1:一种新型黏液纤维肉瘤的患者来源细胞系。
Hum Cell. 2022 Nov;35(6):1993-2001. doi: 10.1007/s13577-022-00749-7. Epub 2022 Aug 10.
8
Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.建立并鉴定了一个新型细胞系,NCC-MFS1-C1,来源于黏液纤维肉瘤患者。
Hum Cell. 2019 Apr;32(2):214-222. doi: 10.1007/s13577-018-00233-1. Epub 2019 Feb 8.
9
Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS3-C1:一种新型黏液纤维肉瘤患者来源细胞系。
Hum Cell. 2021 Jul;34(4):1266-1273. doi: 10.1007/s13577-021-00548-6. Epub 2021 May 15.
10
Recombinant Methioninase Increases Eribulin Efficacy 16-fold in Highly Eribulin-resistant HT1080 Fibrosarcoma Cells, Demonstrating Potential to Overcome the Clinical Challenge of Drug-resistant Soft-tissue Sarcoma.重组甲硫氨酸酶使高度耐埃博利珠单抗的 HT1080 纤维肉瘤细胞对埃博利珠单抗的疗效增加 16 倍,这表明有可能克服软组织肉瘤耐药的临床挑战。
Anticancer Res. 2024 Sep;44(9):3777-3783. doi: 10.21873/anticanres.17202.

本文引用的文献

1
A novel patient-derived immortalised cell line of myxofibrosarcoma: a tool for preclinical drugs testing and the generation of near-patient models.一种新型的黏液纤维肉瘤患者源性永生化细胞系:一种用于临床前药物测试和近患者模型生成的工具。
BMC Cancer. 2023 Dec 6;23(1):1194. doi: 10.1186/s12885-023-11658-9.
2
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?黏液纤维肉瘤建模:我们目前的状况如何以及还缺少什么?
Cancers (Basel). 2023 Oct 25;15(21):5132. doi: 10.3390/cancers15215132.
3
Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation.
一种携带异柠檬酸脱氢酶1(IDH1)突变的新型去分化软骨肉瘤细胞系SMU-DDCS的建立与鉴定
Hum Cell. 2023 Nov;36(6):2195-2203. doi: 10.1007/s13577-023-00944-0. Epub 2023 Jul 15.
4
Establishment and characterization of NCC-MFS6-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS6-C1:一种新型黏液纤维肉瘤的患者来源细胞系。
Hum Cell. 2022 Nov;35(6):1993-2001. doi: 10.1007/s13577-022-00749-7. Epub 2022 Aug 10.
5
Establishment and Characterization of NCC-MFS5-C1: A Novel Patient-Derived Cell Line of Myxofibrosarcoma.建立并鉴定 NCC-MFS5-C1:一种新型黏液纤维肉瘤患者来源细胞系。
Cells. 2022 Jan 8;11(2):207. doi: 10.3390/cells11020207.
6
Pazopanib in rare histologies of metastatic soft tissue sarcoma.帕唑帕尼用于转移性软组织肉瘤的罕见组织学类型
Ecancermedicalscience. 2021 Sep 2;15:1281. doi: 10.3332/ecancer.2021.1281. eCollection 2021.
7
Establishment and characterization of NCC-MFS4-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS4-C1:一种新型黏液纤维肉瘤的患者来源细胞系。
Hum Cell. 2021 Nov;34(6):1911-1918. doi: 10.1007/s13577-021-00589-x. Epub 2021 Aug 12.
8
Establishment and characterization of NCC-MFS3-C1: a novel patient-derived cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS3-C1:一种新型黏液纤维肉瘤患者来源细胞系。
Hum Cell. 2021 Jul;34(4):1266-1273. doi: 10.1007/s13577-021-00548-6. Epub 2021 May 15.
9
Establishment and characterization of NCC-MFS2-C1: a novel patient-derived cancer cell line of myxofibrosarcoma.建立并鉴定 NCC-MFS2-C1:一种新型黏液纤维肉瘤的患者来源癌细胞系。
Hum Cell. 2021 Jan;34(1):246-253. doi: 10.1007/s13577-020-00420-z. Epub 2020 Sep 1.
10
Periplocin mediates TRAIL-induced apoptosis and cell cycle arrest in human myxofibrosarcoma cells via the ERK/p38/JNK pathway.杠柳毒苷通过ERK/p38/JNK信号通路介导TRAIL诱导的人黏液纤维肉瘤细胞凋亡和细胞周期阻滞。
Phytomedicine. 2020 Jun 5;76:153262. doi: 10.1016/j.phymed.2020.153262.